0001181431-12-024659.txt : 20120418 0001181431-12-024659.hdr.sgml : 20120418 20120418205118 ACCESSION NUMBER: 0001181431-12-024659 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120410 FILED AS OF DATE: 20120418 DATE AS OF CHANGE: 20120418 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TIDMARSH GEORGE F CENTRAL INDEX KEY: 0001287235 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-24274 FILM NUMBER: 12767080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4365 EXECUTIVE DRIVE, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584526600 MAIL ADDRESS: STREET 1: 4365 EXECUTIVE DRIVE, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92121 4/A 1 rrd342429.xml FORM 4/A X0305 4/A 2012-04-10 2012-04-12 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001287235 TIDMARSH GEORGE F 4370 LA JOLLA VILLAGE DRIVE, SUITE 400 SAN DIEGO CA 92122 1 1 0 0 President and CEO Stock Option (Right to Buy) 0.06 2012-04-10 4 A 0 506300087 0 A 2022-04-10 Common Stock 506300087 506300087 D This amendment is being filed solely to correct the number of derivative securities acquired and the number of derivative securities beneficially owned following the reported transaction, which were reported incorrectly in the original Form 4 due to an administrative error. The option shall vest and become exercisable with respect to one-quarter of the underlying shares on January 19, 2013 and, with respect to the remaining shares, monthly thereafter over the next three years. By: /s/ George F. Tidmarsh 2012-04-17